Welcome to the e-CCO Library!

P521: Correlation of histological assessment of mucosal healing with long-term clinical and patient-reported outcomes in patients with moderately to severely active ulcerative colitis treated with upadacitinib: results from the Phase 3 U-ACHIEVE maintenance trial
Year: 2022
Source: ECCO'22
Authors: Parkes, G.(1);Ungaro, R.(2);Danese, S.(3);Abreu, M.(4);Arenson, E.(5);Zhou, W.(6);Ilo, D.(6);Laroux, F.S.(7);Deng, H.(8);Sanchez Gonzalez, Y.(6);Peyrin-Biroulet, L.(9);
Created: Friday, 11 February 2022, 3:56 PM
P521: Effectiveness of ustekinumab as therapy for chronic antibiotic refractory pouchitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Outtier, A.(1)*;Louis, E.(2);Dewit, O.(3);Schops, G.(1);Verstockt, B.(1);Sabino, J.(1);Vermeire, S.(1);Ferrante, M.(1);
Created: Friday, 14 July 2023, 11:05 AM
P521: Evaluation of adalimumab effectiveness in paediatric patients with ulcerative colitis in clinical practice
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Steiner1*, C. Liu2, E. King2, E. Israel3, B. Pasternak4, M. Schaefer5, S. Chen2, J. Pratt2, A. Lazar6, M. Bereswill6, A. Robinson7, R. Colletti8, ImproveCareNow Network9

Created: Thursday, 21 February 2019, 9:14 AM
P521: Pre-operative enteral nutrition in adults with Crohn’s disease: effect on gut microbiota and disease outcomes
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. P. Costa Santos*1, C. Palmela1, J. Torres1, A. Ferreira1, S. Velho1, L. Glória1, S. Ouro1, I. Gordo2, M. Cravo1

Created: Friday, 22 February 2019, 9:41 AM
P522 Prior pharmacotherapy patterns among patients with IBD in the USA initiating biologic therapy
Year: 2020
Source:

ECCO'20 Vienna

Authors:

R. Bornheimer1, S. Hass2, A. NAG3, G. Oster1

Created: Thursday, 30 January 2020, 10:12 AM
P522: A multicenter study to validate Magnetic Resonance Enterography against histological assessments of stenotic disease in patients with Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Coimbra A.*1, Rimola J.2, Cuatrecasas M.2, De Hertogh G.3, Van Assche G.3, Vanslembrouck R.3, Glerup H.4, Hedemann Nielsen A.4, Hagemann-Madsen R.4, Bouhnik Y.5, Zappa M.5, Cazals-Hatem D.5, D'Haens G.6, Stoker J.6, Meijer S.6, Rogler G.7, Boss A.7, Weber A.7, Zhao R.1, Keir M.1, Scherl A.1, deCrespigny A.1, Lu T.1, Panes J.2

Created: Wednesday, 20 February 2019, 10:36 AM
P522: Effectiveness of tofacitinib in a real-world Israeli cohort of patients with moderate-severe ulcerative colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Avni Biron, I.(1);Bar-Gil Shitrit , A.(2);Koslowsky, B.(2);Kopylov, U.(3);Levartovsky, A.(3);Weisshof, R.(4);Aviv-Cohen, N.(5);Maharshak, N.(5);Hovel, D.(6);Naftali, T.(7);Goren, I.(1);Snir, I.(1);ollech, J.(1);Banai, H.(1);Lena, B.(1);Dotan, I.(1);Yanai, H.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P522: Expression of markers of early atherosclerosis in inflammatory bowel disease: a prospective cohort of a single referral centre
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

B. Scrivo*1, M. G. Cilluffo1, A. Tuttolomondo2, D. Torres2, V. Calvaruso1, A. Pinto2, M. Cappello3

Created: Friday, 22 February 2019, 9:41 AM
P522: Kono-S anastomosis reduces endoscopic and surgical post-operative recurrence in Crohn's disease. The SuPREMe-CD Trial Update.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Luglio, G.(1)*;Rispo, A.(2);Tropeano, F.P.(3);Giglio, M.C.(4);Cricrì, M.(4);Imperatore, N.(5);De Sire, R.(4);Guarino, A.D.(4);Bucci, L.(6);Castiglione, F.(4);De Palma, G.D.(4);
Created: Friday, 14 July 2023, 11:05 AM
P522: Soluble sMadCAM1 and retinoic acid are potential tools for therapeutic drug monitoring in inflammatory bowel disease s under vedolizumab: A proof of concept
Year: 2018
Source: ECCO '18 Vienna
Authors:

X. Roblin1*, N. Williet1, G. Boschetti2, B. Flourie2, E. Del Tedesco3, L. Peyrin Biroulet4, J.m. Phelip3, S. Nancey2, S. Paul5

Created: Thursday, 21 February 2019, 9:14 AM
P522: Upadacitinib Promotes Histologic and Endoscopic Mucosal Healing: Results from the Upadacitinib Ulcerative Colitis Phase 3 Program
Year: 2022
Source: ECCO'22
Authors: Peyrin-Biroulet, L.(1);Siegel, C.(2);Tanida, S.(3);Bossuyt, P.(4);Torres, E.(5);Dubinsky, M.(6);Baert, F.(7);Zhou, W.(8);Klaff, J.(8);Berg, S.(8);Laroux, F.S.(9);Sanchez Gonzalez, Y.(8);Yao, X.(8);Zhou, Q.(8);Reinisch, W.(10);
Created: Friday, 11 February 2022, 3:56 PM
P523 Improvement of quality of life and continence in patients with distal ulcerative colitis treated by mesalazine: QUARTZ study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

T. Paupard1, F. Gonzalez2, L. Siproudhis3, L. Peyrin-Biroulet4, Thierry Paupard

Created: Thursday, 30 January 2020, 10:12 AM
P523: Association between pharmacokinetics of adalimumab and disease outcome in Japanese patients with biologics naïve Crohn's disease: a subanalysis of DIAMOND trial
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Motoya S.*1, Nakase H.2, Matsumoto T.3, Watanabe K.4, Hisamatsu T.5, Yoshimura N.6, Ishida T.7, Kato S.8, Nakagawa T.9, Nagahori M.10, Esaki M.11, Matsui T.12, Naito Y.13, Kanai T.14, Suzuki Y.15, Nojima M.16, Watanabe M.10, Hibi T.17 the DIAMOND Study Group

Created: Wednesday, 20 February 2019, 10:36 AM
P523: effectiveness of biological treatments for inflammatory bowel disease in the elderly patients
Year: 2022
Source: ECCO'22
Authors: Suarez Ferrer, C.J.(1);Mesonero, F.(2);Caballol, B.(3);Ballester, M.P.(4);Baston Rey, I.(5);Castaño Garcia, A.(6);Miranda Bautista, J.(7);Saiz Chumillas, R.(8);Benitez, J.M.(9);Sanchez Delgado, L.(10);Lopez-Garcia, A.(11);Rubin de Celix, C.(12);Martin-Arranz, M.D.(13);Lopez Sanroman, A.(2);Fernandez-Clotet, A.(3);Merino Murgui, V.(14);Calviño Suarez, C.(5);Florez, P.(6);Lobato Matilla, M.E.(7);Sicilia, B.(8);Soto Escribano, P.(15);Maroto Martin, C.(10);Alonso Abreu, I.(16);Melcarne, L.(17);Elena , P.G.(18);Iyo, E.(19);Elosua Gonzalez, A.(20);Saiz, E.(21);Hernandez Villalba, L.(22);Perez Galindo, P.(23);Torrealba Medina , L.(24);Monsalve Alonso , S.(25);Olmos Jerez, J.A.(26);Dueñas Sadornil , C.(27);Barreiro-De Acosta, M.(5);
Created: Friday, 11 February 2022, 3:56 PM
P523: Endoscopic balloon dilatation is safe and has a high success rate in patients with stricturing Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

E. Lim1,2,3, M. Thai2,4, P. Hendy2,4, M. Alchlaihawi5, R. Leong5,6,7, S. Connor6,8, W. Ng6,8, B. Gu6,8, D. van Langenberg9,10, L. Thin11,12, J. Schulberg13,14, M. Kamm13,14, R. Gilmore15, K. Taylor15, O. Sallis16,17, J. Andrews16,17, C. Daker18,19, M. Barclay18,19, G. Wark6,20, S. Ghaly6,20, M. Begun6, K. Krishnaprasad21, J. Begun*2,4,22

Created: Friday, 22 February 2019, 9:41 AM
P523: New guidance on therapeutic drug monitoring; potential clinical and cost implication
Year: 2018
Source: ECCO '18 Vienna
Authors:

R. Felwick*, H. Johnson, H. Dewhurst, E. Cadogan, C. Hovell, S. Weaver, S. McLaughlin

Created: Thursday, 21 February 2019, 9:14 AM
P523: Quality, safety and equity of care outcomes for inflammatory bowel disease patients at four tertiary referral centres in Australia using a cloud based management system Crohn's Colitis Care (CCCare): A real world observational study.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Cheema, M.(1)*;Narouz, I.(2);Pipicella, J.(3);Garden , F.(4);Lynch, K.(5);Andrews, J.(5);Ghaly, S.(2);Connor, S.(1);
Created: Friday, 14 July 2023, 11:05 AM
P523: Survey to identify patient characteristics, treatment preferences and impact of inflammatory bowel disease (IBD) on quality of life across 7 countries in Europe
Year: 2021
Source: ECCO'21 Virtual
Authors: Fiorino, G.(1);Bent-Ennakhil, N.(2);Varriale, P.(3);Braegger, F.(2);Hoefkens, E.(4);
Created: Wednesday, 2 June 2021, 4:12 PM
P524 Administration and monitoring of biologic therapy in patients with inflammatory bowel disease: A national Danish survey
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Volmar1, S. Wildt2,3, L.K. Munck2,3

Created: Thursday, 30 January 2020, 10:12 AM
P524: Active smoking and personal concerns about treatment can impair adherence to adalimumab in inflammatory bowel diseases: A prospective evaluation
Year: 2018
Source: ECCO '18 Vienna
Authors:

I. Bruna-Barranco1, P. Alarcon2, A. Lué3,4, C. Gargallo3,4, E. Alfambra4, M. Gimeno5, F. Gomollon2,3,4,6*

Created: Thursday, 21 February 2019, 9:14 AM